| 000 | 01548 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516185850.0 | ||
| 264 | 0 | _c20150310 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/onc.2013.534 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, L | |
| 245 | 0 | 0 |
_aEGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma. _h[electronic resource] |
| 260 |
_bOncogene _cJan 2015 |
||
| 300 |
_a129-134 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aErbB Receptors _xmetabolism |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xmetabolism |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTemozolomide |
| 700 | 1 | _aPuliyappadamba, V T | |
| 700 | 1 | _aChakraborty, S | |
| 700 | 1 | _aRehman, A | |
| 700 | 1 | _aVemireddy, V | |
| 700 | 1 | _aSaha, D | |
| 700 | 1 | _aSouza, R F | |
| 700 | 1 | _aHatanpaa, K J | |
| 700 | 1 | _aKoduru, P | |
| 700 | 1 | _aBurma, S | |
| 700 | 1 | _aBoothman, D A | |
| 700 | 1 | _aHabib, A A | |
| 773 | 0 |
_tOncogene _gvol. 34 _gno. 1 _gp. 129-134 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2013.534 _zAvailable from publisher's website |
| 999 |
_c23390258 _d23390258 |
||